key: cord-0753873-5v5sa2co
authors: Wu, Jianhua; Mamas, Mamas A.; de Belder, Mark A.; Deanfield, John E.; Gale, Chris P.
title: Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic
date: 2021-03-02
journal: J Am Coll Cardiol
DOI: 10.1016/j.jacc.2020.12.039
sha: 8226113fa9094b1d30ea87cfa8e26fee52711a3c
doc_id: 753873
cord_uid: 5v5sa2co

nan

We studied the daily incidence of admissions with heart failure (HF) and myocardial infarction ( Given that the period cohort for this analysis cannot determine a nadir in admissions, rates of admissions may decline further. This is important because earlier work from the United Kingdom described how delays to seeking help were temporally related to an inflation in deaths from a range of acute cardiovascular diseases (4, 5) . Clear public messaging is necessary to prevent further unintended consequences of social distancing mandates to reduce the spread of severe acute respiratory syndrome coronavirus 2. serial ECG showed a progression from normal ECG to LPFB ( Figure 1 ).

All 6 of 6 (100%) study group participants who underwent CMR showed LV late gadolinium enhancement (inferolateral/lateral in 4, inferoseptal in 1, and LV diffuse in 1).

In total, 6 of 8 control subjects with LPFB underwent CMR because of a family history of SCD (n ¼ 2),

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

The Covid-19 pandemic and the incidence of acute myocardial infarction

Patient response, treatments and mortality for acute myocardial infarction during the COVID-19 pandemic

Place and causes of acute cardiovascular mortality during the COVID-19 pandemic

Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study